This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Richter Gedeon Nyrt.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Eszter Gábor: Innovator in Thiadiazine Derivatives
Introduction
Eszter Gábor is a prominent inventor based in Tura, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly through her work on thiadiazine derivatives. Her innovative approach has led to advancements in the modulation of α7 nicotinic acetylcholine receptor activity, which is crucial for various therapeutic applications.
Latest Patents
Eszter Gábor holds 1 patent related to her research on thiadiazine derivatives. This patent encompasses not only the derivatives themselves but also their pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates, and hydrates. The invention is aimed at developing pharmaceutical compositions that utilize these compounds for their modulating effects on receptor activity in mammalian subjects.
Career Highlights
Eszter Gábor is associated with Richter Gedeon Nyrt., a leading pharmaceutical company in Hungary. Her work at the company has been instrumental in advancing research and development in the field of medicinal chemistry. She has demonstrated a strong commitment to innovation and excellence in her field.
Collaborations
Eszter has collaborated with notable colleagues, including István Ledneczki and János Éles. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to impactful scientific discoveries.
Conclusion
Eszter Gábor's contributions to the field of pharmaceuticals through her work on thiadiazine derivatives exemplify her dedication to innovation. Her patent and collaborations highlight her role as a significant figure in advancing medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
